These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6474281)

  • 1. [NK and ADCC activities of peripheral lymphocytes in patients with rheumatoid arthritis].
    Ohara M; Igarashi S; Kobashi C; Shirato M; Yoshida N; Kumakawa H; Sakuma H; Watanabe K; Nanamiya M; Yoshida H
    Ryumachi; 1984 Apr; 24(2):87-93. PubMed ID: 6474281
    [No Abstract]   [Full Text] [Related]  

  • 2. The cell populations mediating natural killing-(NK) and antibody-dependent cell-mediated cytotoxicity are only partially identical.
    Bardos P; Altman J; Guillou PJ; Carnaud C
    Clin Exp Immunol; 1981 Mar; 43(3):534-9. PubMed ID: 7285391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NK activity in the peripheral blood of patients with progressive polyarthritis. II. Correlation with indicators of cell-mediated immunity].
    Strejcek J; Jíra M; Horký J; Antosová E
    Cas Lek Cesk; 1985 Nov; 124(47):1455-7. PubMed ID: 4064096
    [No Abstract]   [Full Text] [Related]  

  • 4. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.
    Fox RI; Fong S; Tsoukas C; Vaughan JH
    J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
    Neville ME
    J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer activity of human lymphocytes against colon cancer cells.
    Helms RA; Bull DM
    Gastroenterology; 1980 Apr; 78(4):738-44. PubMed ID: 7353760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity within the population of NK and K cells.
    Jensen PJ; Koren HS
    J Immunol; 1980 Jan; 124(1):395-8. PubMed ID: 6985645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressed natural killer activity in rheumatoid arthritis and its in vitro augmentation with interferon and N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium salt (CCA), an anti-arthritis agent.
    Itoh K; Saitoh F; Kumagai K; Kosaka S
    Ryumachi; 1981; 21 Suppl():69-74. PubMed ID: 6178171
    [No Abstract]   [Full Text] [Related]  

  • 17. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of murine large granular lymphocytes. I. Identification as effector cells in NK and K cytotoxicities.
    Kumagai K; Itoh K; Suzuki R; Hinuma S; Saitoh F
    J Immunol; 1982 Jul; 129(1):388-94. PubMed ID: 6979572
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural and antibody-dependent cellular cytotoxicity in patients with active sarcoidosis.
    Antonaci S; Moretti AM; Bonomo L
    Allergol Immunopathol (Madr); 1983; 11(1):40-6. PubMed ID: 6858806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of rheumatoid synovial fluid lymphocytes. I. Evidence for activated natural killer- (NK) like cells.
    Silver RM; Redelman D; Zvaifler NJ; Naides S
    J Immunol; 1982 Apr; 128(4):1758-63. PubMed ID: 6460811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.